Optimization of adefovir therapy in chronic hepatitis B according to baseline predictors and on-treatment HBV DNA: a 5-Year prospective study

BACKGROUND: Adefovir Dipivoxil (ADV) is an important agent to suppress hepatitis B virus (HBV) replication with suboptimal effect on virological and serological response. To optimize Adefovir therapy in chronic hepatitis B (CHB) patients with hepatitis B e antigen (HBeAg) positive, we studied the ba...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Lu, Hui, Geng, Da Ying, Shen, Fei, Zhang, Jing Yao, Lu, Bing, Ma, Li Xian
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2011
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3205069/
https://ncbi.nlm.nih.gov/pubmed/21936898
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1743-422X-8-444
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados